Elgendy D, Elmahy R, Amer A, Ibrahim H, Eltantawy A, Mansour F
Pathog Glob Health. 2023; 118(1):47-64.
PMID: 37978995
PMC: 10769145.
DOI: 10.1080/20477724.2023.2285182.
Lin L, Tang Z, Shi Z, Guo Q, Xiong H
J Immunol Res. 2022; 2022:9591544.
PMID: 35178460
PMC: 8844150.
DOI: 10.1155/2022/9591544.
Yang J, He Y, Li Y, Zhang X, Wong Y, Shen S
Pharmacol Ther. 2020; 216:107697.
PMID: 33035577
PMC: 7537645.
DOI: 10.1016/j.pharmthera.2020.107697.
Hassett M, Roepe P
Am J Trop Med Hyg. 2019; 101(6):1204-1211.
PMID: 31642425
PMC: 6896886.
DOI: 10.4269/ajtmh.19-0379.
White N, Watson J, Ashley E
Sci Rep. 2017; 7(1):12132.
PMID: 28935919
PMC: 5608907.
DOI: 10.1038/s41598-017-12483-4.
Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.
Fanello C, Onyamboko M, Lee S, Woodrow C, Setaphan S, Chotivanich K
BMC Infect Dis. 2017; 17(1):575.
PMID: 28818049
PMC: 5561573.
DOI: 10.1186/s12879-017-2678-0.
Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.
Shah S, Ullah F, Khan S, Shah S, De Matas M, Hussain Z
Drug Des Devel Ther. 2016; 10:3837-3850.
PMID: 27920499
PMC: 5125812.
DOI: 10.2147/DDDT.S114962.
Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
Saunders D, Khemawoot P, Vanachayangkul P, Siripokasupkul R, Bethell D, Tyner S
Antimicrob Agents Chemother. 2012; 56(11):5484-93.
PMID: 22869581
PMC: 3486599.
DOI: 10.1128/AAC.00044-12.
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials.
Moehrle J, Duparc S, Siethoff C, van Giersbergen P, Craft J, Arbe-Barnes S
Br J Clin Pharmacol. 2012; 75(2):524-37.
PMID: 22759078
PMC: 3558805.
DOI: 10.1111/j.1365-2125.2012.04368.x.
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.
Wahajuddin , Singh S, Raju K, Nafis A, Puri S, Jain G
Malar J. 2011; 10:293.
PMID: 21985153
PMC: 3305926.
DOI: 10.1186/1475-2875-10-293.
Coartem: the journey to the clinic.
Premji Z
Malar J. 2009; 8 Suppl 1:S3.
PMID: 19818170
PMC: 2760238.
DOI: 10.1186/1475-2875-8-S1-S3.
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
Nagelschmitz J, Voith B, Wensing G, Roemer A, Fugmann B, Haynes R
Antimicrob Agents Chemother. 2008; 52(9):3085-91.
PMID: 18559649
PMC: 2533467.
DOI: 10.1128/AAC.01585-07.
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
Krudsood S, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertsuk S
Southeast Asian J Trop Med Public Health. 2003; 34(2):316-21.
PMID: 12971556
PMC: 3123522.
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.
Krudsood S, Wilairatana P, Vannaphan S, Treeprasertsuk S, Silachamroon U, Phomrattanaprapin W
Southeast Asian J Trop Med Public Health. 2003; 34(1):54-61.
PMID: 12971515
PMC: 3114420.
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.
Borrmann S, Adegnika A, Missinou M, Binder R, Issifou S, Schindler A
Antimicrob Agents Chemother. 2003; 47(3):901-4.
PMID: 12604519
PMC: 149309.
DOI: 10.1128/AAC.47.3.901-904.2003.
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
Lefevre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D
Br J Clin Pharmacol. 2002; 54(5):485-92.
PMID: 12445027
PMC: 1874456.
DOI: 10.1046/j.1365-2125.2002.01696.x.
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.
Looareesuwan S, Oosterhuis B, Schilizzi B, Sollie F, Wilairatana P, Krudsood S
Br J Clin Pharmacol. 2002; 53(5):492-500.
PMID: 11994055
PMC: 1874374.
DOI: 10.1046/j.1365-2125.2002.01590.x.
Pharmacokinetics of artemisinin-type compounds.
Navaratnam V, Mansor S, Sit N, Grace J, Li Q, Olliaro P
Clin Pharmacokinet. 2000; 39(4):255-70.
PMID: 11069212
DOI: 10.2165/00003088-200039040-00002.
Artemisinin derivatives for treating uncomplicated malaria.
McIntosh H, Olliaro P
Cochrane Database Syst Rev. 2000; (2):CD000256.
PMID: 10796519
PMC: 6532741.
DOI: 10.1002/14651858.CD000256.
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Ezzet F, Mull R, Karbwang J
Br J Clin Pharmacol. 1998; 46(6):553-61.
PMID: 9862244
PMC: 1873796.
DOI: 10.1046/j.1365-2125.1998.00830.x.